期刊文献+

倍美力辅助克罗米酚促排卵治疗中对子宫内膜及宫颈黏液的作用 被引量:3

下载PDF
导出
摘要 【目的】探讨倍美力辅助克罗米酚(CC)促排卵治疗中对于宫内膜及宫颈黏液的作用。【方法】对60例服克罗米酚促排卵治疗不孕的妇女,随机分为对照组30例,月经周期第5天服克罗米酚50mg/d,连服5d;治疗组30例,月经周期第5天服克罗米酚50mg/d,连服5d,月经周期第8天加服倍美力0.625mg/d,连服10d。卵泡成熟时观察子宫内膜厚度及宫颈黏液评分。【结果】治疗组子宫内膜厚度及宫颈黏液评分均高于对照组(P<0.05)。【结论】倍美力辅助克罗米酚促排卵治疗可改善子宫内膜厚度及提高宫颈黏液评分,有利于受精卵着床,提高促排卵治疗的临床疗效。
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第B03期179-180,共2页 Journal of Sun Yat-Sen University:Medical Sciences
  • 相关文献

参考文献3

  • 1Biljan MM, Mahutte NG, Tulandi T, et al. Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end organs[J]. Fertil Steril, 1999, 71 (4):633-8.
  • 2周士平,王树玉,黄醒华.辅助生育技术中常用的促超排卵药物[J].中国优生与遗传杂志,2003,11(1):78-80. 被引量:10
  • 3Ohno Y, Fujimoto Y. Endometrial oestrogen and progesterone receptors and their relationship to sonographic appearance of the endometrium[J].Hum Reprod Update, 1998,4(5):560-4.

二级参考文献15

  • 1庄广伦,翁世湘,周灿权.小剂量生长激素在体外受精超排卵周期中的作用[J].中华妇产科杂志,1994,29(8):471-474. 被引量:36
  • 2[1]Biljan MM, Mahutte NG, Tulandi T, et al. Prospective randomized double-blind trail of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end ovgans. Fertil Steril, 1999, 71(4):633-638
  • 3[3]De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrone. Fertil Steril, 1999, 72(2) :282-285
  • 4[4]Branigan EF, Estes MA. Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by reprent CC treatment. Fertil Steril, 1999, 71(3) :544-546
  • 5[5]Matikainen T, DE Leew R, Mannaerts B, et al. Circulating bioactive and immunoreactive recombinant human follicle simulating hormone after administration to gonadotropin deficient subjects. Fertil Steril, 1994, 61:62-69
  • 6[6]De Leew R, Mulders J, Voortman G, et al. Structure function relationship of recombinant follicle stimulating hormone. Hum Reprod,1996, 2: 361-369
  • 7[7]Hoomans EHM, Andersen AN, et al. A prospective, randomized clinical trail comparing 150IU recombinant follicles stimulating hormone( Metrodin-HP)in a fixed dose regimen in women undergoing ovarian stimulation. Hum Reprod, 1999, 14:2442-2447
  • 8[8]Out HJ, Mannaerts BMJL, Driessen SGAT, et al. A prospective,randomized assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone in in-vitro fertilization. Hum Reprod, 1995, 10: 2534-2540
  • 9[9]Jinno M, Satou M, Ubukata Y, et al. Administration of hCG for IVF-ET based on the serum LH concentration: the importance of synchronization with endogenous LH rises [J ]. Fertil Steril, 1995,63(4) :859-865
  • 10[10]Priou G. Management of ovarian hyperstimulation syndrome during IVF program [J ]. Contracept Fertil Sex, 1996, 24(9): 647-649

共引文献9

同被引文献52

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部